Navigation Links
Pre-pregnancy diabetes increases risk of MRSA among new mothers
Date:7/1/2013

Washington, DC, July 1, 2013 Pregnant women with diabetes are more than three times as likely as mothers without diabetes to become infected with methicillin-resistant Staphylococcus aureus (MRSA) before hospital discharge, according to a study in the July issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

The study aim was to investigate the extent to which pre-pregnancy and gestational diabetes are associated with MRSA infection. Researchers found that pre-pregnancy diabetes was associated with increased risk of MRSA following delivery, but found no association between MRSA and gestational diabetes.

Researchers from the University of California, Los Angeles analyzed more than 3.5 million delivery-related hospital admissions from the Nationwide Inpatient Sample (NIS), a system that accounts for 20 percent of community hospitals in the United States. Of these admissions, 5.3 percent of mothers (185,514 women) acquired diabetes during their pregnancy (gestational diabetes) and nearly one percent (28,939) had pre-pregnancy diabetes. The researchers identified 563 cases of invasive MRSA among the mothers following delivery. To the extent that infection site information was available, the most frequent sources of infection were skin (30.9 percent), urinary tract (6.4 percent), other genitourinary sites (5.2 percent), wound infections (3.0 percent) and septicemia (2.0 percent).

"When combined with previous research showing increased risk of certain infections in diabetic persons, it seems likely that diabetic women are at increased risk of MRSA infection compared with other women admitted for delivery of an infant," conclude the authors. "As we wait for further research on this topic, it might seem prudent for hospitals to be vigilant about possible MRSA risk among diabetic women in labor and delivery."

MRSA is a type of staph bacteria that is resistant to certain antibiotics and is an important cause of illness and sometimes death, especially among patients who have been hospitalized.


'/>"/>

Contact: Liz Garman
egarman@apic.org
202-454-2604
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. Mothers Pre-Pregnancy Weight Tied to Kids IQ, Study Says
2. Study shows link between pre-pregnancy obesity and lower test scores
3. UCI researchers awarded $2.27 million to create novel diabetes treatments
4. Huge falls in diabetes mortality in UK and Canada since mid-1990s
5. RSNA: Exercise Benefits Patients with Type 2 Diabetes
6. Exercise benefits patients with type 2 diabetes
7. New analysis shows that patients with Type 2 diabetes and mild renal impairment had similar improvement in blood sugar control and experienced less hypoglycemia with JANUVIA (sitagliptin) compared to sulfonylurea
8. Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease
9. Loyola receives $1.5 million grant to study vitamin D for diabetes and depression
10. NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes
11. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin), KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) Now Available in Pharmacies in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... that for a second year in a row; they are the recipient of ... in the industry voted on the award at Design Connections 2017. Top A&D ...
(Date:3/27/2017)... California (PRWEB) , ... March 27, 2017 , ... The ... to its customers. First National Capital has added 10 new sales professionals over the ... its sales positions by 15 additional new hires over the course of 2017. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center will ... April 3rd to commemorate the two-year anniversary of the facility. The event will ... two great years while also familiarizing themselves with the facility. , In the ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin Harper ... prestigious award honoring the top influencers on RealSelf—the most trusted online destination to ... and clinics. , In 2016, more than 82 million people visited RealSelf to ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships ... world’s premier prehospital trauma education developed in cooperation with the American College of ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LightIntegra Technology Inc. today announced that its ... President and Chief Executive Officer effective March 13, 2017. ... Directors of LightIntegra. Paul Geyer will continue ... "This is the perfect time for Bill ... We,ve selected a very strong leader at a time ...
(Date:3/27/2017)... VANCOUVER, British Columbia, March 27, 2017  Sophiris ... "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company ... with urological diseases, today reported fourth quarter and ... highlights. Key Corporate Highlights: ... for Localized Prostate Cancer. During 2016, the Company ...
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . ... therapies to address serious pulmonary diseases, today announced that it ... disease, cystic fibrosis and asthma to its Scientific Advisory ... Richard B. Moss , MD, former chief ... of the Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology: